Extensive personal experience - Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents
dc.contributor.author | Mulatero, P | |
dc.contributor.author | Stowasser, M | |
dc.contributor.author | Loh, KC | |
dc.contributor.author | Fardella, CE | |
dc.contributor.author | Gordon, RD | |
dc.contributor.author | Mosso, L | |
dc.contributor.author | Gomez Sanchez, CE | |
dc.contributor.author | Veglio, F | |
dc.contributor.author | Young, WF | |
dc.date.accessioned | 2024-01-10T12:38:55Z | |
dc.date.available | 2024-01-10T12:38:55Z | |
dc.date.issued | 2004 | |
dc.description.abstract | Primary aldosteronism (PA) is a common form of endocrine hypertension previously believed to account for less than 1% of hypertensive patients. Hypokalemia was considered a prerequisite for pursuing diagnostic tests for PA. Recent studies applying the plasma aldosterone/plasma renin activity ratio (ARR) as a screening test have reported a higher prevalence. This study is a retrospective evaluation of the diagnosis of PA from clinical centers in five continents before and after the widespread use of the ARR as a screening test. The application of this strategy to a greater number of hypertensives led to a 5- to 15-fold increase in the identification of patients affected by PA. Only a small proportion of patients ( between 9 and 37%) were hypokalemic. The annual detection rate of aldosterone-producing adenoma (APA) increased in all centers ( by 1.3-6.3 times) after the wide application of ARR. Aldosterone-producing adenomas constituted a much higher proportion of patients with PA in the four centers that employed adrenal venous sampling ( 28 - 50%) than in the center that did not (9%). In conclusion, the wide use of the ARR as a screening test in hypertensive patients led to a marked increase in the detection rate of PA. | |
dc.fechaingreso.objetodigital | 2024-05-15 | |
dc.format.extent | 6 páginas | |
dc.fuente.origen | WOS | |
dc.identifier.doi | 10.1210/jc.2003-031337 | |
dc.identifier.issn | 0021-972X | |
dc.identifier.pubmedid | MEDLINE:15001583 | |
dc.identifier.uri | https://doi.org/10.1210/jc.2003-031337 | |
dc.identifier.uri | https://repositorio.uc.cl/handle/11534/77118 | |
dc.identifier.wosid | WOS:000220030700002 | |
dc.information.autoruc | Medicina;Mosso L;S/I;88201 | |
dc.issue.numero | 3 | |
dc.language.iso | en | |
dc.nota.acceso | contenido parcial | |
dc.pagina.final | 1050 | |
dc.pagina.inicio | 1045 | |
dc.publisher | ENDOCRINE SOC | |
dc.revista | JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM | |
dc.rights | acceso restringido | |
dc.subject | RAT-HEART | |
dc.subject | PRIMARY HYPERALDOSTERONISM | |
dc.subject | HYPERTENSIVE PATIENTS | |
dc.subject | BLOOD-PRESSURE | |
dc.subject | PREVALENCE | |
dc.subject | PATHOPHYSIOLOGY | |
dc.subject | INFLAMMATION | |
dc.subject | MANAGEMENT | |
dc.subject | BLOCKER | |
dc.subject | SYSTEM | |
dc.subject.ods | 03 Good Health and Well-being | |
dc.subject.odspa | 03 Salud y bienestar | |
dc.title | Extensive personal experience - Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents | |
dc.type | artículo | |
dc.volumen | 89 | |
sipa.codpersvinculados | 88201 | |
sipa.index | WOS | |
sipa.index | Scopus | |
sipa.trazabilidad | Carga SIPA;09-01-2024 |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- 2024-05-15. Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents.pdf
- Size:
- 2.85 KB
- Format:
- Adobe Portable Document Format
- Description: